# Genetic variations associated with immediate hypersensitivity reactions to iodinated contrast media: A whole exome sequencing study

**Authors:** Noeul Kang, Hoshik Kwon, Myung-Eui Seo, Byung-Joo Min, Byung-Jae Lee, Ju Han Kim, Ho Yun Lee

PMC · DOI: 10.1371/journal.pone.0345313 · PLOS One · 2026-03-26

## TL;DR

This study identifies genetic variations linked to allergic reactions to iodinated contrast media used in CT scans, suggesting potential roles for metabolic and immune pathways.

## Contribution

The study is the first to use whole exome sequencing to identify genetic factors associated with immediate hypersensitivity to iodinated contrast media.

## Key findings

- FASTKD1 variant rs12618227 was more common in controls, suggesting a protective role against hypersensitivity.
- CNV analysis found a significant SIRPB1 deletion in patients with hypersensitivity reactions.
- FASTKD1, HACL1, and SIRPB1 showed high expression in granulocytes, particularly basophils, linking them to immune responses.

## Abstract

The use of iodinated contrast media (ICM) in computed tomography (CT) has increased significantly; however, hypersensitivity reactions (HSRs) remain a concern. This study aimed to investigate genetic factors associated with ICM-induced immediate HSRs using whole exome sequencing (WES).

We conducted a case–control study including 20 patients with ICM-induced immediate HSRs and 11 controls who had received ICM at least three times without HSRs. WES was performed with DNA extracted from saliva samples. Analyses included single-nucleotide variant (SNV) association testing using the Cochran–Armitage trend test with false discovery rate (FDR) correction, gene-wise variant burden (GVB) analysis, and copy number variation (CNV) detection using complementary algorithms.

A variant in FAST kinase domain 1 (FASTKD1, rs12618227) was significantly more prevalent in the control group compared with the case group (72.7% vs. 5.0%, FDR p < 0.10), suggesting a protective role. GVB analysis revealed lower scores for FASTKD1 and 2-hydroxyacyl-CoA lyase 1 (HACL1) in the control group (nominal p < 0.001). CNV analysis identified a significant Signal Regulatory Protein Beta 1 (SIRPB1) deletion in the case group (5/20, 25.0%). In contrast, CNVs in Mucin 12, cell surface associated (MUC12) were observed in both groups. Immune cell expression data showed high expression of FASTKD1, HACL1, and SIRPB1 in granulocytes, particularly basophils.

FASTKD1 and HACL1, which are involved in mitochondrial and metabolic regulation, and SIRPB1, which participates in innate immune signaling, were identified as candidate genes potentially associated with ICM-induced immediate HSRs. These suggest a possible contribution of both metabolic and immune regulatory pathways to genetic susceptibility and require validation in larger, independent cohorts before clinical application.

## Linked entities

- **Genes:** FASTKD1 (FAST kinase domains 1) [NCBI Gene 79675], HACL1 (2-hydroxyacyl-CoA lyase 1) [NCBI Gene 26061], SIRPB1 (signal regulatory protein beta 1) [NCBI Gene 10326], MUC12 (mucin 12, cell surface associated) [NCBI Gene 10071]

## Full-text entities

- **Genes:** Fcgr3 (Fc receptor, IgG, low affinity III) [NCBI Gene 14131] {aka CD16}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, FCER1A (Fc epsilon receptor Ia) [NCBI Gene 2205] {aka FCE1A, FCERIA, FcERI}, SIRPB1 (signal regulatory protein beta 1) [NCBI Gene 10326] {aka CD172b, SIRB1, SIRP-BETA-1}, FASTKD1 (FAST kinase domains 1) [NCBI Gene 79675], Hacl1 (2-hydroxyacyl-CoA lyase 1) [NCBI Gene 56794] {aka 1600020H07Rik, Hpcl, Phyh2}, ND3 (NADH dehydrogenase subunit 3) [NCBI Gene 4537] {aka MTND3}, Sirpb1a (signal-regulatory protein beta 1A) [NCBI Gene 320832] {aka 9930027N05Rik, SIRP-beta, Sirpb, Sirpb1}, HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) [NCBI Gene 3123] {aka DRB1, HLA-DR1B, HLA-DRB, SS1}, Igh-V7183 (immunoglobulin heavy chain (V7183 family)) [NCBI Gene 16059] {aka B9-scFv, IgG, IgH, IgVH1(VSG), VH7183, VI24H}, Fastkd1 (FAST kinase domains 1) [NCBI Gene 320720] {aka 5330408N05Rik, mKIAA1800}, HACL1 (2-hydroxyacyl-CoA lyase 1) [NCBI Gene 26061] {aka 2-HPCL, HPCL, HPCL2, PHYH2}, MUC12 (mucin 12, cell surface associated) [NCBI Gene 10071] {aka MUC-11, MUC-12, MUC11}
- **Diseases:** ICM (MESH:D005119), HPA (MESH:C483996), dyspnea (MESH:D004417), Mitochondrial damage (MESH:D028361), toxicities (MESH:D064420), cardiovascular disease (MESH:D002318), hypotension (MESH:D007022), nausea (MESH:D009325), CT (MESH:C000719218), abdominal pain (MESH:D015746), dizziness (MESH:D004244), syncope (MESH:D013575), pruritus (MESH:D011537), anaphylactic (MESH:D000707), inflammation (MESH:D007249), drug hypersensitivity (MESH:D004342), vomiting (MESH:D014839), angioedema (MESH:D000799), HSRs (MESH:D006967), urticaria (MESH:D014581), neurologic compromise (MESH:D009461), hepatic dysfunction (MESH:D008107), Cancer (MESH:D009369), stridor (MESH:D012135), chills (MESH:D023341), hypoxia (MESH:D000860), erythema (MESH:D004890), chest tightness (MESH:D002637)
- **Chemicals:** lipid (MESH:D008055), iopromide (MESH:C038192), ioversol (MESH:C054871), iohexol (MESH:D007472), fatty acid (MESH:D005227), iomeprol (MESH:C057937), ICM (-), hydrocortisone (MESH:D006854), iobitridol (MESH:C093233), steroid (MESH:D013256), iopamidol (MESH:D007479), arachidonic acid (MESH:D016718), AA (MESH:D000596), histamine (MESH:D006632), reactive nitrogen species (MESH:D026361), chlorpheniramine (MESH:D002744)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** rs12618227, rs905650

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13020841/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13020841/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC13020841/full.md

---
Source: https://tomesphere.com/paper/PMC13020841